Editors: David M Gershenson Professor and Deputy Chairman, Department of Gynecologic Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA William P McGuire Professor of Medical Oncology, Emory University, Atlanta, Georgia, USA
A multi-authored, clinical work describing the controversies in the management of the difficult problem of ovarian cancer, and offering individual views and recommendations of the experts followed by commentary from the editors. The editors have chosen a panel format as a novel approach to assisting the gynaecologist and oncologist in management.
¾ Addresses difficult problems of ovarian cancer management and detection ¾ Provides specific and personal guidance from the experts ¾ Comments on the book proposal include: David Gershenson is an extremely well respected gynecologic oncologist and surgeon who has edited a major gynecologic surgery text for WB Saunders. The MD Anderson Cancer Center is one of the premier cancer institutes internationally. William P. McGuire was instrumental in the launch of the important drug taxol and is a leader in the medical oncology field.""
- 1. Screening for epithelial ovarian cancer
- 2. The role of prophylactic oophorectomy
- 3. Adjuvant therapy for early stage ovarian cancer
- 4. Primary cytoreductive surgery for advanced stage disease
- 5. Second-look laparotomy
- 6. Second cytoreductive surgery
- 7. Primary chemotherapy for advanced stage disease
- 8. Dose Intensity: Is it important?
- 9. Salvage chemotherapy for refractory disease
- 10. Management of borderline tumors of the ovary
- 11. Role of radiation therapy in the management of ovarian cancer
- 12. Role of radioisotope therapy in the management of ovarian cancer
- 13. Palliative care and quality of life considerations in the management of ovarian cancer
- 14. What is standard post-therapy surveillance?
- 15. Role of hormonal therapy in management of ovarian cancer
- 16. Intraperitoneal chemotherapy
- 17. Clinical applications of basic science investigations
- 18. Management of ovarian germ cell tumors
- 19. Management of sex cord stromal tumours